【摘 要】
：
HIV/AIDS can be considered as a kind of infectious disease mainly related to the behavior in general though it can be transmitted by unscreened blood transfusion or mother to infant transmission.The b
【机 构】
：
Centers for Diseases Control and Prevention,Guangxi Zhuangzu Autonomous Region,Nanning 530021, P.R.C
【出 处】
：
2006中国天津世界艾滋病日科技会议
论文部分内容阅读
HIV/AIDS can be considered as a kind of infectious disease mainly related to the behavior in general though it can be transmitted by unscreened blood transfusion or mother to infant transmission.The behavior includes sharing syringe among drug abuser,commercial sex and multiple sexual partners among adults.There has been estimated 650,000 HIV/AIDS in China so far,and the sexual contact cases increased remarkably,which was first time more than that from sharing syringe of drug abuser.HIV/AIDS has been spreading from high risk population to the general population right now in China.
其他文献
FusoGen Pharmaceuticals,Inc.is a leading Chinese biotech company based in Tianjin and Beijing,China.The company was founded in 2002 by Jason G.Zhou,an expert in structural biology and computer-assiste
The HIV-1 reverse transcriptase (RT) has been a successful target for chemotherapeutic intervention.However,new drugs are urgently needed for systemic or for topical use as a microbicide due to the ev
NIFEVIROC,a small molecular compound,is a proprietary drug candidate which is developed by TARGETDRUG and holds great promise in inhibiting HIV-1 replication in infected paitents.Preclinical studies s
The continuing emergence of resistant strains of the human immunodeficiency virus type 1 (HIV-1) makes the search for new anti-HIV-1 agents very urgent One of the most attractive target for selective
Until the end of 2005,twenty-seven drags targeted to the human immunodeficiency virus (HIV) have been approved by the U.S.Food and Drug Administration (FDA).Although great progress has been made in th
Human Immunodeficiency virus (HIV) is composed of two viral types:HIV-1 and HIV-2.HIV-1 is pandemic.Sequence analysis of HIV-1 has allowed to classify this virus into three groups:M (major),O (outlier
Combination therapy with reverse transcriptase and protease inhibitors is the most common current treatment of HIV-1 infection.Despite the success of this therapy,it has adverse effects and drug resis
We identified,characterized and defined the molecular mechanism of two novel inhibitors of HIV-1.These small molecules are effective against multiple steps of the viral life cycle.They inhibit HIV-1 a
In confronting the pandemic,the most obvious strategy is to make treatment as widely available as possible.Beyond treatment,however,the focus should be on prevention.Large inflows of new funding prese
Drug resistance in HIV-1 protease can also occasionally confer a change in the substrate specificity.Through the use of computational techniques,a relationship can be determined between the substrate